Wells Fargo
BNGO icon

Wells Fargo’s Bionano Genomics BNGO Stock Holding History

Wells Fargo’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132 Buy
113
+83
+277% +$106 ﹤0.01% 6482
2025
Q4 		$46 Sell
30
-83
-73% -$144 ﹤0.01% 6532
2025
Q3 		$193 Hold
113
– – ﹤0.01% 6348
2025
Q2 		$371 Sell
113
-1
-0.9% -$4 ﹤0.01% 6404
2025
Q1 		$318 Sell
114
-2
-2% -$13 ﹤0.01% 6301
2024
Q4 		$2K Buy
116
+80
+222% +$1.37K ﹤0.01% 6191
2024
Q3 		$990 Buy
36
+13
+57% +$404 ﹤0.01% 6126
2024
Q2 		$926 Sell
23
-5
-18% -$275 ﹤0.01% 6098
2024
Q1 		$1.88K Buy
28
+17
+155% +$1.27K ﹤0.01% 6045
2023
Q4 		$1.3K Buy
11
+1
+10% +$104 ﹤0.01% 6169
2023
Q3 		$1.83K Buy
10
+1
+11% +$262 ﹤0.01% 6103
2023
Q2 		$3.42K Sell
9
-85
-90% -$38.4K ﹤0.01% 6132
2023
Q1 		$62.8K Buy
94
+87
+1,243% +$77.3K ﹤0.01% 5050
2022
Q4 		$5.69K Sell
7
-2
-22% -$2.52K ﹤0.01% 5733
2022
Q3 		$9K Sell
9
-9
-50% -$11.9K ﹤0.01% 5711
2022
Q2 		$15K Sell
18
-257
-93% -$264K ﹤0.01% 5575
2022
Q1 		$425K Sell
275
-167
-38% -$225K ﹤0.01% 4524
2021
Q4 		$793K Buy
442
+80
+22% +$214K ﹤0.01% 4303
2021
Q3 		$1.2M Buy
362
+343
+1,805% +$1.2M ﹤0.01% 4088
2021
Q2 		$84K Sell
19
-46
-71% -$182K ﹤0.01% 5354
2021
Q1 		$315K Buy
65
+55
+550% +$310K ﹤0.01% 4944
2020
Q4 		$18K Buy
10
+9
+900% +$3.36K ﹤0.01% 5877
2020
Q3 		$1K Buy
+1
New +$388 ﹤0.01% 6180
2020
Q2 		– Hold
0
– – – 6291
2020
Q1 		– Hold
0
– – – 6203

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Wells Fargo's BNGO Position: Q1 2026 in Review

Wells Fargo increased its Bionano Genomics (BNGO) stake by 277% in Q1 2026, buying an estimated $106 and bringing the position to 113 shares worth $132. The position accounts for ﹤0.01% of the portfolio, ranked #6482.

Wells Fargo first reported a position in BNGO in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.2M in Q3 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Wells Fargo held 113 shares of Bionano Genomics worth $132 as of Q1 2026.
  • Wells Fargo bought 83 Bionano Genomics shares in Q1 2026, an estimated $106.
  • Bionano Genomics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6482 holding.
  • Wells Fargo first reported a position in Bionano Genomics in Q3 2020 and has held it in 23 quarters since.
  • Wells Fargo's Bionano Genomics position peaked at $1.2M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.